skip to Main Content

Cancer Services

Gastrointestinal Cancer

Please see below all current gastrointestinal cancer clinical trials of the Central Coast Cancer Centre.

Medical Oncology clinical trials

Name: OXTOX

Can oxaliplatin neurotoxicity be reduced with ibudilast in people with metastatic colorectal cancer – a phase II randomised study

Principal Investigator: Dr Matthew Wong
Study Coordinator: Bronwyn Raymond
Status: Recruiting
Condition: Colorectal Cancer
External page link More information about OXTOX

Name: INTEGRATE II

A Randomised Phase III Double-Blind Placebo-Controlled Study of regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC)

Principal Investigator: Dr Matthew Wong
Study Coordinator: Bronwyn Raymond
Status: Recruiting
Condition: Gastrointestinal Cancer
External page link More information about INTEGRATE II

Name: Protocol 8951-CL-5201

A phase 2, open-label, randomized study to assess the antitumor activity and safety of Zolbetuximab (IMAB362) in combination with Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as first line treatment in subjects with Claudin 18.2 (CLDN 18.2) positive, metastatic pancreatic adenocarcinoma.

Principal Investigator: Dr Matthew Wong
Study Coordinator: Michelle Dixon
Status: Recruiting
Condition: Pancreatic Cancer
External page link More information about Protocol 8951-CL-5201

Name: MK 6482

An Open-label, multicentre, phase II study to evaluate the efficacy and safety of pembrolizumab plus lenvatinib in combination with belzutifan in multiple solid tumours.

Principal Investigator: Dr Matthew Wong
Study Coordinator: Cassandra Rubio
Status: Recruiting
Condition: Hepatocellular, Endometrial, Oesophageal Cancer
External page link More information about MK 6482

Name: STAR-221

A Randomised, open-label, Multicentre Phase 3 Trial of Domvanalimab, Zimberelimab, and Chemotherapy in Participants with Previously Untreated Locally Advanced Unresectable or Metastatic gastric Gastroesophageal Junction, and Esophageal Adenocarcinoma

Principal Investigator: Dr Craig Kukard
Study Coordinator: Abraham Mathews
Status: Recruiting
Condition: Gastro-Oesophageal Cancer
External page link More information about STAR-221

Radiation Oncology clinical trials

Name: LARK

The LARK Clinical Trial Liver Ablative Radiotherapy utilising Kilovoltage Intrafraction Monitoring (KIM).

Principal Investigator: Dr Simon Tang
Study Coordinator: Richard Clayton
Status: Recruiting
Condition: Liver Cancer
External page link More information about LARK

More information

For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:

Internal page Research and Clinical Trials

Back To Top